| biological regulation (GO:0065007) | 0.39 | 24 | CACNA1C, KCNE1, NPPA, KCNE3, CASQ2, SCN4B, NOS1AP, CACNB2, KCNJ5, RYR2, HCN4, KCNH2, KCNE2, JUP, ANK2, SCN5A, KCNJ8, SCN1B, AKAP9, LIG3, KCNQ1, DSG2, KCNJ2, SNTA1 |
| regulation of biological process (GO:0050789) | 0.45 | 24 | CACNA1C, KCNE1, NPPA, KCNE3, CASQ2, SCN4B, NOS1AP, CACNB2, KCNJ5, RYR2, HCN4, KCNH2, KCNE2, JUP, ANK2, SCN5A, KCNJ8, SCN1B, AKAP9, LIG3, KCNQ1, DSG2, KCNJ2, SNTA1 |
| regulation of localization (GO:0032879) | 1.94 | 23 | CACNA1C, KCNE1, NPPA, KCNE3, CASQ2, SCN4B, NOS1AP, CACNB2, KCNJ5, RYR2, HCN4, KCNH2, KCNE2, JUP, ANK2, SCN5A, KCNJ8, SCN1B, AKAP9, KCNQ1, DSG2, KCNJ2, SNTA1 |
| regulation of transport (GO:0051049) | 2.24 | 22 | CACNA1C, KCNE1, NPPA, KCNE3, CASQ2, SCN5A, NOS1AP, CACNB2, KCNJ5, RYR2, HCN4, KCNH2, KCNE2, JUP, ANK2, SCN4B, KCNJ8, SCN1B, AKAP9, KCNQ1, KCNJ2, SNTA1 |
| regulation of biological quality (GO:0065008) | 1.68 | 22 | CACNA1C, KCNE1, NPPA, KCNE3, CASQ2, SCN5A, NOS1AP, CACNB2, RYR2, HCN4, KCNH2, KCNE2, JUP, ANK2, SCN4B, KCNJ8, SCN1B, AKAP9, KCNQ1, DSG2, KCNJ2, SNTA1 |
| single-organism process (GO:0044699) | 0.48 | 22 | CACNA1C, KCNE1, ANK2, KCNE3, CASQ2, SCN5A, CACNB2, KCNJ5, RYR2, HCN4, KCNH2, KCNE2, JUP, NPPA, SCN4B, KCNJ8, SCN1B, AKAP9, LIG3, KCNQ1, DSG2, KCNJ2 |
| regulation of membrane potential (GO:0042391) | 3.89 | 21 | CACNA1C, AKAP9, RYR2, SCN5A, SCN4B, NPPA, HCN4, KCNE3, KCNE1, CASQ2, KCNH2, JUP, KCNE2, KCNJ2, CACNB2, DSG2, ANK2, KCNQ1, SNTA1, NOS1AP, SCN1B |
| cellular process (GO:0009987) | 0.26 | 21 | CACNA1C, AKAP9, RYR2, SCN5A, CASQ2, ANK2, HCN4, NPPA, KCNE3, KCNQ1, JUP, KCNE2, KCNJ2, CACNB2, LIG3, DSG2, KCNJ5, KCNH2, KCNE1, KCNJ8, SCN1B |
| single-organism cellular process (GO:0044763) | 0.65 | 21 | CACNA1C, AKAP9, RYR2, SCN5A, KCNE1, ANK2, HCN4, NPPA, KCNE3, CASQ2, KCNH2, JUP, KCNE2, KCNJ2, CACNB2, LIG3, DSG2, KCNJ5, KCNQ1, KCNJ8, SCN1B |
| regulation of ion transport (GO:0043269) | 3.4 | 21 | AKAP9, CACNA1C, RYR2, SCN5A, KCNE1, ANK2, HCN4, KCNH2, NOS1AP, CASQ2, KCNE3, KCNE2, KCNQ1, CACNB2, NPPA, KCNJ5, SCN4B, SNTA1, KCNJ8, KCNJ2, SCN1B |
| regulation of ion transmembrane transport (GO:0034765) | 3.77 | 21 | CACNA1C, AKAP9, RYR2, SCN5A, SCN4B, ANK2, HCN4, KCNH2, KCNE1, CASQ2, KCNE3, KCNE2, KCNJ2, CACNB2, NPPA, KCNJ5, KCNQ1, SNTA1, KCNJ8, NOS1AP, SCN1B |
| regulation of transmembrane transport (GO:0034762) | 3.74 | 21 | AKAP9, CACNA1C, RYR2, SCN5A, KCNE1, ANK2, HCN4, KCNH2, NOS1AP, CASQ2, KCNE3, KCNE2, KCNQ1, CACNB2, NPPA, KCNJ5, SCN4B, SNTA1, KCNJ8, KCNJ2, SCN1B |
| multicellular organismal process (GO:0032501) | 1.45 | 20 | AKAP9, CACNA1C, RYR2, SCN5A, KCNE1, NPPA, HCN4, KCNQ1, CASQ2, KCNH2, JUP, KCNE2, KCNJ2, CACNB2, DSG2, ANK2, SCN4B, SNTA1, KCNJ8, SCN1B |
| regulation of system process (GO:0044057) | 3.53 | 20 | AKAP9, CACNA1C, RYR2, SCN5A, KCNE1, DSG2, HCN4, KCNQ1, NOS1AP, KCNH2, JUP, KCNE2, KCNJ2, CACNB2, SCN1B, ANK2, SCN4B, SNTA1, NPPA, CASQ2 |
| regulation of heart contraction (GO:0008016) | 4.35 | 20 | AKAP9, CACNA1C, RYR2, SCN5A, KCNE1, NPPA, HCN4, KCNQ1, NOS1AP, KCNH2, JUP, KCNE2, KCNJ2, CACNB2, DSG2, ANK2, CASQ2, SNTA1, SCN4B, SCN1B |
| regulation of cellular process (GO:0050794) | 0.5 | 20 | AKAP9, CACNA1C, RYR2, SCN5A, KCNE1, LIG3, HCN4, NPPA, KCNH2, NOS1AP, KCNE3, KCNE2, KCNQ1, JUP, DSG2, ANK2, CASQ2, SNTA1, KCNJ2, SCN1B |
| regulation of heart rate (GO:0002027) | 5.29 | 20 | AKAP9, CACNA1C, RYR2, SCN5A, CASQ2, NPPA, HCN4, KCNQ1, NOS1AP, KCNH2, JUP, KCNE2, KCNJ2, CACNB2, DSG2, ANK2, KCNE1, SNTA1, SCN4B, SCN1B |
| regulation of blood circulation (GO:1903522) | 4.05 | 20 | CACNA1C, AKAP9, RYR2, SCN5A, CASQ2, NPPA, HCN4, KCNQ1, NOS1AP, KCNH2, JUP, KCNE2, KCNJ2, CACNB2, DSG2, ANK2, KCNE1, SNTA1, SCN4B, SCN1B |
| regulation of multicellular organismal process (GO:0051239) | 1.87 | 20 | AKAP9, CACNA1C, RYR2, SCN5A, KCNE1, DSG2, HCN4, KCNQ1, NOS1AP, KCNH2, JUP, KCNE2, KCNJ2, CACNB2, SCN1B, ANK2, SCN4B, SNTA1, NPPA, CASQ2 |
| establishment of localization (GO:0051234) | 1.48 | 19 | AKAP9, CACNA1C, RYR2, SCN5A, KCNE1, ANK2, HCN4, KCNH2, CASQ2, KCNE3, JUP, KCNE2, KCNQ1, CACNB2, KCNJ5, SCN4B, KCNJ8, KCNJ2, SCN1B |
| localization (GO:0051179) | 1.4 | 19 | AKAP9, CACNA1C, RYR2, SCN5A, KCNE1, ANK2, HCN4, KCNH2, CASQ2, KCNE3, JUP, KCNE2, KCNJ2, CACNB2, KCNJ5, KCNQ1, SCN4B, KCNJ8, SCN1B |
| regulation of metal ion transport (GO:0010959) | 3.94 | 18 | CACNA1C, AKAP9, RYR2, SCN5A, SCN4B, NPPA, KCNH2, KCNE1, CASQ2, KCNE3, KCNE2, KCNJ2, CACNB2, ANK2, KCNQ1, SNTA1, NOS1AP, SCN1B |
| transport (GO:0006810) | 1.51 | 18 | CACNA1C, AKAP9, RYR2, SCN5A, CASQ2, ANK2, HCN4, KCNQ1, KCNE3, KCNE2, KCNJ2, CACNB2, KCNJ5, KCNH2, KCNE1, SCN4B, KCNJ8, SCN1B |
| regulation of cation transmembrane transport (GO:1904062) | 4.4 | 18 | AKAP9, CACNA1C, RYR2, SCN5A, KCNE1, KCNJ2, KCNH2, NOS1AP, KCNE3, KCNE2, KCNQ1, CACNB2, SCN1B, ANK2, SCN4B, SNTA1, NPPA, CASQ2 |
| positive regulation of biological process (GO:0048518) | 1.2 | 17 | AKAP9, RYR2, CASQ2, NPPA, KCNQ1, KCNE1, KCNH2, JUP, KCNE2, KCNJ2, CACNB2, KCNE3, ANK2, SCN5A, SCN4B, NOS1AP, SCN1B |
| single organism signaling (GO:0044700) | 3.25 | 17 | AKAP9, CACNA1C, RYR2, SCN5A, CASQ2, HCN4, KCNH2, KCNQ1, JUP, KCNE2, KCNJ2, CACNB2, DSG2, ANK2, KCNE1, SCN4B, SCN1B |
| response to stimulus (GO:0050896) | 1.22 | 17 | AKAP9, RYR2, SCN5A, CASQ2, LIG3, HCN4, NPPA, KCNH2, KCNQ1, KCNE2, KCNJ2, JUP, DSG2, ANK2, KCNE1, KCNJ8, SCN1B |
| signaling (GO:0023052) | 3.25 | 17 | CACNA1C, AKAP9, RYR2, SCN5A, CASQ2, HCN4, KCNQ1, KCNE1, KCNH2, JUP, KCNE2, KCNJ2, CACNB2, DSG2, ANK2, SCN4B, SCN1B |
| ion transport (GO:0006811) | 2.66 | 17 | CACNA1C, RYR2, SCN5A, CASQ2, ANK2, HCN4, KCNE3, KCNE1, KCNQ1, KCNE2, KCNJ2, CACNB2, KCNJ5, KCNH2, SCN4B, KCNJ8, SCN1B |
| single-multicellular organism process (GO:0044707) | 1.78 | 16 | CACNA1C, AKAP9, RYR2, SCN5A, HCN4, KCNH2, KCNQ1, JUP, KCNE2, KCNJ2, CACNB2, DSG2, ANK2, KCNE1, SCN4B, SCN1B |
| positive regulation of transport (GO:0051050) | 2.9 | 16 | AKAP9, KCNJ2, RYR2, SCN5A, KCNE1, NPPA, KCNH2, NOS1AP, KCNE3, JUP, KCNE2, KCNQ1, CACNB2, ANK2, SCN4B, SCN1B |
| cation transport (GO:0006812) | 3.11 | 16 | CACNA1C, RYR2, SCN5A, KCNE1, ANK2, HCN4, KCNH2, KCNE3, KCNE2, KCNJ2, CACNB2, KCNJ5, KCNQ1, SCN4B, KCNJ8, SCN1B |
| ion transmembrane transport (GO:0034220) | 3.08 | 16 | CACNA1C, RYR2, SCN5A, CASQ2, HCN4, KCNQ1, KCNE3, KCNE2, KCNJ2, CACNB2, KCNJ5, KCNH2, KCNE1, SCN4B, KCNJ8, SCN1B |
| metal ion transport (GO:0030001) | 3.36 | 16 | CACNA1C, RYR2, SCN5A, KCNE1, ANK2, HCN4, KCNE3, KCNH2, KCNE2, KCNJ2, CACNB2, KCNJ5, KCNQ1, SCN4B, KCNJ8, SCN1B |
| transmembrane transport (GO:0055085) | 2.72 | 16 | CACNA1C, RYR2, SCN5A, HCN4, KCNE3, KCNE1, CASQ2, KCNH2, KCNE2, KCNJ2, CACNB2, KCNJ5, KCNQ1, SCN4B, KCNJ8, SCN1B |
| multicellular organismal signaling (GO:0035637) | 5.36 | 15 | CACNA1C, AKAP9, SCN5A, HCN4, KCNQ1, KCNH2, JUP, KCNE2, KCNJ2, CACNB2, DSG2, ANK2, KCNE1, SCN4B, SCN1B |
| cardiac conduction (GO:0061337) | 5.54 | 15 | CACNA1C, AKAP9, KCNE1, HCN4, KCNQ1, KCNH2, JUP, KCNE2, KCNJ2, CACNB2, DSG2, ANK2, SCN5A, SCN4B, SCN1B |
| regulation of membrane repolarization (GO:0060306) | 6.4 | 15 | AKAP9, CASQ2, NPPA, KCNQ1, KCNE1, KCNH2, KCNE3, KCNE2, KCNJ2, ANK2, SCN5A, SNTA1, SCN4B, NOS1AP, SCN1B |
| positive regulation of ion transport (GO:0043270) | 4.36 | 15 | AKAP9, RYR2, SCN5A, KCNE1, NPPA, KCNH2, NOS1AP, KCNE3, KCNE2, KCNJ2, CACNB2, ANK2, KCNQ1, SCN4B, SCN1B |
| regulation of heart rate by cardiac conduction (GO:0086091) | 6.33 | 15 | CACNA1C, AKAP9, SCN5A, SCN4B, HCN4, KCNQ1, KCNH2, JUP, KCNE2, KCNJ2, CACNB2, DSG2, ANK2, KCNE1, SCN1B |
| inorganic cation transmembrane transport (GO:0098662) | 3.55 | 15 | CACNA1C, RYR2, SCN5A, SCN4B, HCN4, KCNE3, KCNE1, KCNH2, KCNE2, KCNJ2, CACNB2, KCNJ5, KCNQ1, KCNJ8, SCN1B |
| inorganic ion transmembrane transport (GO:0098660) | 3.38 | 15 | CACNA1C, RYR2, SCN5A, HCN4, KCNQ1, KCNE3, KCNE2, KCNJ2, CACNB2, KCNJ5, KCNH2, KCNE1, SCN4B, KCNJ8, SCN1B |
| response to chemical (GO:0042221) | 1.98 | 15 | AKAP9, RYR2, SCN5A, KCNE1, NPPA, HCN4, KCNQ1, KCNH2, KCNE2, JUP, DSG2, ANK2, CASQ2, KCNJ8, SCN1B |
| cation transmembrane transport (GO:0098655) | 3.43 | 15 | CACNA1C, RYR2, SCN5A, KCNE1, HCN4, KCNE3, KCNQ1, KCNE2, KCNJ2, CACNB2, KCNJ5, KCNH2, SCN4B, KCNJ8, SCN1B |
| regulation of molecular function (GO:0065009) | 1.78 | 14 | AKAP9, RYR2, KCNE1, NPPA, KCNQ1, NOS1AP, KCNE3, JUP, KCNE2, CACNB2, ANK2, CASQ2, SCN4B, SCN1B |
| system process (GO:0003008) | 2.3 | 14 | RYR2, KCNE1, HCN4, KCNQ1, CASQ2, KCNH2, KCNJ2, CACNB2, NPPA, SCN5A, SNTA1, SCN4B, KCNJ8, SCN1B |
| positive regulation of cellular process (GO:0048522) | 1.3 | 14 | AKAP9, RYR2, SCN5A, CASQ2, NPPA, KCNH2, NOS1AP, KCNQ1, KCNE2, KCNJ2, JUP, ANK2, KCNE1, SCN1B |
| cellular response to stimulus (GO:0051716) | 1.97 | 13 | AKAP9, RYR2, SCN5A, CASQ2, LIG3, HCN4, KCNQ1, KCNH2, KCNE2, KCNJ2, JUP, NPPA, KCNE1 |
| cardiac muscle cell action potential (GO:0086001) | 6.33 | 13 | CACNA1C, RYR2, SCN5A, SCN4B, HCN4, KCNQ1, KCNH2, KCNE2, KCNJ2, ANK2, KCNE1, SNTA1, SCN1B |
| regulation of ion transmembrane transporter activity (GO:0032412) | 4.55 | 13 | AKAP9, RYR2, KCNE1, NPPA, KCNQ1, NOS1AP, KCNE3, KCNE2, CACNB2, ANK2, CASQ2, SCN4B, SCN1B |
| regulation of transmembrane transporter activity (GO:0022898) | 4.52 | 13 | AKAP9, RYR2, KCNE1, NPPA, KCNQ1, NOS1AP, KCNE3, KCNE2, CACNB2, ANK2, CASQ2, SCN4B, SCN1B |
| regulation of transporter activity (GO:0032409) | 4.45 | 13 | AKAP9, RYR2, KCNE1, NPPA, KCNQ1, NOS1AP, KCNE3, KCNE2, CACNB2, ANK2, CASQ2, SCN4B, SCN1B |
| action potential (GO:0001508) | 5.42 | 13 | CACNA1C, RYR2, SCN5A, HCN4, KCNH2, KCNQ1, KCNE2, KCNJ2, ANK2, KCNE1, SNTA1, SCN4B, SCN1B |
| single-organism localization (GO:1902578) | 2.09 | 13 | CACNA1C, RYR2, KCNE1, ANK2, HCN4, KCNH2, KCNE3, KCNE2, KCNJ2, JUP, KCNJ5, KCNQ1, KCNJ8 |
| cardiac muscle cell action potential involved in contraction (GO:0086002) | 6.47 | 12 | CACNA1C, RYR2, SCN5A, KCNH2, KCNQ1, KCNE2, KCNJ2, ANK2, KCNE1, SNTA1, SCN4B, SCN1B |
| regulation of muscle contraction (GO:0006937) | 4.75 | 12 | CACNA1C, RYR2, CASQ2, NPPA, HCN4, NOS1AP, KCNQ1, DSG2, KCNJ2, JUP, ANK2, SCN5A |
| regulation of striated muscle contraction (GO:0006942) | 5.38 | 12 | CACNA1C, RYR2, CASQ2, NPPA, HCN4, NOS1AP, KCNQ1, DSG2, KCNJ2, JUP, ANK2, SCN5A |
| positive regulation of cation transmembrane transport (GO:1904064) | 5.17 | 12 | AKAP9, RYR2, KCNE1, NPPA, KCNH2, NOS1AP, KCNE3, KCNE2, KCNJ2, CACNB2, ANK2, KCNQ1 |
| regulation of cardiac muscle contraction (GO:0055117) | 5.57 | 12 | CACNA1C, RYR2, CASQ2, NPPA, HCN4, NOS1AP, KCNQ1, DSG2, KCNJ2, JUP, ANK2, SCN5A |
| single-organism transport (GO:0044765) | 2.18 | 12 | CACNA1C, RYR2, KCNE1, ANK2, HCN4, KCNH2, KCNE3, KCNE2, KCNJ2, KCNJ5, KCNQ1, KCNJ8 |
| regulation of cardiac muscle cell membrane repolarization (GO:0099623) | 6.68 | 12 | AKAP9, KCNE1, NPPA, KCNQ1, NOS1AP, KCNH2, KCNE2, ANK2, SCN5A, SNTA1, SCN4B, SCN1B |
| regulation of muscle system process (GO:0090257) | 4.51 | 12 | CACNA1C, RYR2, CASQ2, NPPA, HCN4, NOS1AP, KCNQ1, DSG2, KCNJ2, JUP, ANK2, SCN5A |
| positive regulation of transmembrane transport (GO:0034764) | 4.99 | 12 | AKAP9, RYR2, KCNE1, NPPA, KCNQ1, NOS1AP, KCNH2, KCNE3, KCNE2, KCNJ2, CACNB2, ANK2 |
| positive regulation of ion transmembrane transport (GO:0034767) | 5.05 | 12 | AKAP9, RYR2, KCNE1, NPPA, KCNQ1, NOS1AP, KCNH2, KCNE3, KCNE2, KCNJ2, CACNB2, ANK2 |
| monovalent inorganic cation transport (GO:0015672) | 3.74 | 12 | SCN5A, KCNE1, HCN4, KCNH2, KCNE3, KCNE2, KCNJ2, KCNJ5, KCNQ1, SCN4B, KCNJ8, SCN1B |
| regulation of potassium ion transmembrane transport (GO:1901379) | 5.62 | 11 | AKAP9, KCNJ2, KCNE1, NPPA, KCNH2, NOS1AP, KCNE3, KCNE2, KCNQ1, ANK2, CASQ2 |
| regulation of potassium ion transport (GO:0043266) | 5.31 | 11 | AKAP9, CASQ2, KCNE1, NPPA, KCNH2, NOS1AP, KCNE3, KCNE2, KCNJ2, ANK2, KCNQ1 |
| muscle system process (GO:0003012) | 4.18 | 11 | RYR2, CASQ2, HCN4, KCNQ1, KCNH2, KCNJ2, NPPA, SCN5A, SNTA1, SCN4B, SCN1B |
| regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 6.84 | 11 | AKAP9, SCN5A, KCNQ1, NOS1AP, KCNH2, KCNE2, ANK2, KCNE1, SNTA1, SCN4B, SCN1B |
| response to organic substance (GO:0010033) | 2.2 | 11 | AKAP9, RYR2, CASQ2, NPPA, HCN4, KCNQ1, DSG2, JUP, ANK2, KCNE1, KCNJ8 |
| developmental process (GO:0032502) | 1.36 | 10 | CACNA1C, RYR2, SCN5A, NPPA, KCNQ1, KCNE2, JUP, DSG2, ANK2, KCNJ8 |
| negative regulation of biological process (GO:0048519) | 1.33 | 10 | RYR2, KCNE1, LIG3, KCNH2, KCNE3, KCNE2, NPPA, KCNQ1, SNTA1, CASQ2 |
| cellular response to chemical stimulus (GO:0070887) | 2.57 | 10 | AKAP9, RYR2, SCN5A, CASQ2, HCN4, KCNH2, KCNQ1, KCNE2, JUP, KCNE1 |
| negative regulation of cellular process (GO:0048523) | 1.41 | 10 | RYR2, KCNE1, LIG3, KCNH2, KCNE3, KCNE2, NPPA, KCNQ1, SNTA1, CASQ2 |
| response to oxygen-containing compound (GO:1901700) | 2.57 | 9 | AKAP9, RYR2, KCNE1, HCN4, KCNQ1, DSG2, JUP, NPPA, KCNJ8 |
| response to endogenous stimulus (GO:0009719) | 2.79 | 9 | AKAP9, RYR2, CASQ2, HCN4, KCNQ1, DSG2, JUP, NPPA, KCNE1 |
| regulation of calcium ion transport (GO:0051924) | 4.38 | 9 | CACNA1C, RYR2, CASQ2, NPPA, NOS1AP, KCNE3, KCNE2, CACNB2, ANK2 |
| regulation of metabolic process (GO:0019222) | 1.02 | 9 | AKAP9, RYR2, LIG3, NOS1AP, KCNQ1, KCNE2, JUP, ANK2, SNTA1 |
| cellular potassium ion transport (GO:0071804) | 4.79 | 9 | KCNE1, HCN4, KCNQ1, KCNH2, KCNE3, KCNE2, KCNJ2, KCNJ5, KCNJ8 |
| potassium ion transmembrane transport (GO:0071805) | 4.79 | 9 | KCNE1, HCN4, KCNH2, KCNE3, KCNE2, KCNJ2, KCNJ5, KCNQ1, KCNJ8 |
| potassium ion transport (GO:0006813) | 4.68 | 9 | KCNE1, HCN4, KCNH2, KCNE3, KCNE2, KCNJ2, KCNJ5, KCNQ1, KCNJ8 |
| response to nitrogen compound (GO:1901698) | 3.12 | 9 | AKAP9, RYR2, CASQ2, HCN4, KCNQ1, JUP, NPPA, KCNE1, KCNJ8 |
| anatomical structure development (GO:0048856) | 1.58 | 9 | CACNA1C, RYR2, SCN5A, KCNQ1, KCNE2, JUP, DSG2, ANK2, KCNJ8 |
| muscle contraction (GO:0006936) | 4.37 | 9 | RYR2, SCN5A, SCN4B, HCN4, KCNH2, KCNQ1, CASQ2, SNTA1, SCN1B |
| regulation of potassium ion transmembrane transporter activity (GO:1901016) | 6.02 | 9 | AKAP9, KCNE1, NPPA, KCNQ1, NOS1AP, KCNE3, KCNE2, ANK2, CASQ2 |
| regulation of calcium ion transmembrane transport (GO:1903169) | 4.98 | 9 | CACNA1C, RYR2, CASQ2, NPPA, NOS1AP, KCNE3, KCNE2, CACNB2, ANK2 |
| regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 9 | AKAP9, RYR2, LIG3, NOS1AP, KCNQ1, KCNE2, JUP, ANK2, SNTA1 |
| positive regulation of molecular function (GO:0044093) | 2.23 | 9 | AKAP9, RYR2, NPPA, NOS1AP, KCNE3, CACNB2, KCNE2, JUP, ANK2 |
| regulation of cation channel activity (GO:2001257) | 5.27 | 9 | KCNE1, NPPA, KCNE3, NOS1AP, KCNQ1, KCNE2, CACNB2, ANK2, CASQ2 |
| response to organic cyclic compound (GO:0014070) | 3.07 | 9 | AKAP9, RYR2, CASQ2, HCN4, KCNQ1, DSG2, JUP, KCNE1, KCNJ8 |
| positive regulation of ion transmembrane transporter activity (GO:0032414) | 5.55 | 8 | AKAP9, RYR2, NPPA, NOS1AP, KCNE3, KCNE2, CACNB2, ANK2 |
| ventricular cardiac muscle cell action potential (GO:0086005) | 7.02 | 8 | RYR2, KCNE1, KCNH2, KCNQ1, KCNE2, ANK2, SCN5A, SNTA1 |
| regulation of cellular component movement (GO:0051270) | 3.08 | 8 | CACNA1C, RYR2, SCN5A, NOS1AP, DSG2, KCNJ2, JUP, ANK2 |
| positive regulation of transporter activity (GO:0032411) | 5.44 | 8 | AKAP9, RYR2, NPPA, NOS1AP, KCNE3, KCNE2, CACNB2, ANK2 |
| regulation of actin filament-based movement (GO:1903115) | 6.33 | 8 | CACNA1C, RYR2, SCN5A, NOS1AP, DSG2, KCNJ2, JUP, ANK2 |
| regulation of calcium ion transmembrane transporter activity (GO:1901019) | 5.49 | 8 | RYR2, CASQ2, NPPA, NOS1AP, KCNE3, KCNE2, CACNB2, ANK2 |
| response to organonitrogen compound (GO:0010243) | 3.2 | 8 | AKAP9, RYR2, CASQ2, HCN4, KCNQ1, JUP, NPPA, KCNE1 |
| regulation of actin filament-based process (GO:0032970) | 3.97 | 8 | CACNA1C, RYR2, SCN5A, NOS1AP, DSG2, KCNJ2, JUP, ANK2 |
| cellular component organization (GO:0016043) | 1.24 | 8 | AKAP9, CASQ2, LIG3, JUP, DSG2, KCNJ2, CACNB2, ANK2 |
| regulation of cardiac muscle cell contraction (GO:0086004) | 6.51 | 8 | CACNA1C, RYR2, SCN5A, NOS1AP, DSG2, KCNJ2, JUP, ANK2 |
| single-organism developmental process (GO:0044767) | 1.49 | 8 | CACNA1C, RYR2, SCN5A, NPPA, KCNQ1, KCNE2, ANK2, KCNJ8 |
| membrane depolarization (GO:0051899) | 5.62 | 8 | CACNA1C, SCN4B, KCNH2, KCNJ2, CACNB2, ANK2, SCN5A, SCN1B |
| signal transduction (GO:0007165) | 1.28 | 8 | CACNA1C, AKAP9, RYR2, CASQ2, NPPA, KCNH2, JUP, ANK2 |
| regulation of action potential (GO:0098900) | 6.07 | 8 | CACNA1C, RYR2, SCN5A, NOS1AP, DSG2, KCNJ2, JUP, ANK2 |
| regulation of signaling (GO:0023051) | 1.72 | 8 | CACNA1C, RYR2, CASQ2, NPPA, NOS1AP, KCNE2, JUP, ANK2 |
| cell communication (GO:0007154) | 3.04 | 8 | CACNA1C, AKAP9, RYR2, CASQ2, CACNB2, ANK2, SCN5A, SCN1B |
| membrane depolarization during action potential (GO:0086010) | 6.07 | 8 | CACNA1C, SCN4B, KCNH2, KCNJ2, CACNB2, ANK2, SCN5A, SCN1B |
| positive regulation of potassium ion transmembrane transport (GO:1901381) | 6.43 | 8 | AKAP9, KCNE1, NPPA, KCNQ1, NOS1AP, KCNH2, KCNJ2, ANK2 |
| cellular component organization or biogenesis (GO:0071840) | 1.22 | 8 | AKAP9, CASQ2, LIG3, JUP, DSG2, KCNJ2, CACNB2, ANK2 |
| positive regulation of potassium ion transport (GO:0043268) | 6.09 | 8 | AKAP9, KCNE1, NPPA, KCNQ1, NOS1AP, KCNH2, KCNJ2, ANK2 |
| cellular response to endogenous stimulus (GO:0071495) | 3.33 | 7 | AKAP9, RYR2, CASQ2, HCN4, KCNQ1, JUP, KCNE1 |
| regulation of primary metabolic process (GO:0080090) | 1.08 | 7 | AKAP9, RYR2, LIG3, NOS1AP, KCNE2, JUP, SNTA1 |
| cellular response to organic cyclic compound (GO:0071407) | 3.93 | 7 | AKAP9, RYR2, CASQ2, HCN4, KCNQ1, JUP, KCNE1 |
| cellular response to organonitrogen compound (GO:0071417) | 3.87 | 7 | AKAP9, RYR2, CASQ2, HCN4, KCNQ1, JUP, KCNE1 |
| cellular response to nitrogen compound (GO:1901699) | 3.79 | 7 | AKAP9, RYR2, CASQ2, HCN4, KCNQ1, JUP, KCNE1 |
| regulation of cellular metabolic process (GO:0031323) | 1.07 | 7 | AKAP9, RYR2, LIG3, NOS1AP, KCNE2, JUP, SNTA1 |
| regulation of homeostatic process (GO:0032844) | 3.65 | 7 | CACNA1C, RYR2, CASQ2, HCN4, ANK2, SCN5A, SCN1B |
| striated muscle contraction (GO:0006941) | 5.37 | 7 | RYR2, CASQ2, KCNH2, KCNQ1, SCN5A, SCN4B, SCN1B |
| cellular response to organic substance (GO:0071310) | 2.78 | 7 | AKAP9, RYR2, CASQ2, HCN4, KCNQ1, JUP, KCNE1 |
| regulation of ion homeostasis (GO:2000021) | 4.44 | 7 | CACNA1C, RYR2, CASQ2, HCN4, ANK2, SCN5A, SCN1B |
| membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 7.09 | 7 | CACNA1C, SCN5A, KCNJ2, CACNB2, ANK2, SCN4B, SCN1B |
| regulation of cell communication (GO:0010646) | 1.73 | 7 | CACNA1C, RYR2, CASQ2, NOS1AP, KCNE2, JUP, ANK2 |
| cardiac muscle contraction (GO:0060048) | 5.88 | 7 | RYR2, SCN5A, CASQ2, KCNH2, KCNQ1, SCN4B, SCN1B |
| cellular response to oxygen-containing compound (GO:1901701) | 3.22 | 6 | AKAP9, RYR2, KCNE1, HCN4, KCNQ1, JUP |
| negative regulation of ion transmembrane transport (GO:0034766) | 5.47 | 6 | KCNE1, KCNE3, KCNQ1, KCNE2, KCNH2, CASQ2 |
| primary metabolic process (GO:0044238) | 0.69 | 6 | AKAP9, KCNE1, LIG3, KCNQ1, KCNH2, NPPA |
| regulation of cellular localization (GO:0060341) | 3.03 | 6 | CACNA1C, RYR2, CASQ2, JUP, ANK2, KCNE1 |
| negative regulation of transport (GO:0051051) | 3.6 | 6 | KCNE1, KCNE3, KCNQ1, KCNE2, KCNH2, CASQ2 |
| organic substance metabolic process (GO:0071704) | 0.63 | 6 | AKAP9, KCNE1, LIG3, KCNQ1, KCNH2, NPPA |
| positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 6 | RYR2, SCN5A, NOS1AP, KCNQ1, NPPA, SCN1B |
| regulation of cardiac muscle cell action potential (GO:0098901) | 6.78 | 6 | CACNA1C, RYR2, NOS1AP, DSG2, JUP, ANK2 |
| negative regulation of cation transmembrane transport (GO:1904063) | 5.65 | 6 | KCNE1, KCNE3, KCNQ1, KCNE2, KCNH2, CASQ2 |
| cellular metabolic process (GO:0044237) | 0.69 | 6 | AKAP9, KCNE1, LIG3, KCNQ1, KCNH2, NPPA |
| negative regulation of potassium ion transport (GO:0043267) | 6.26 | 6 | KCNE1, KCNE3, KCNQ1, KCNE2, KCNH2, CASQ2 |
| negative regulation of ion transport (GO:0043271) | 4.94 | 6 | KCNE1, KCNE3, KCNQ1, KCNE2, KCNH2, CASQ2 |
| metabolic process (GO:0008152) | 0.58 | 6 | AKAP9, KCNE1, LIG3, KCNQ1, KCNH2, NPPA |
| regulation of delayed rectifier potassium channel activity (GO:1902259) | 6.84 | 6 | KCNE1, KCNE3, NOS1AP, KCNQ1, KCNE2, NPPA |
| positive regulation of cation channel activity (GO:2001259) | 6.17 | 6 | ANK2, NOS1AP, KCNE3, KCNE2, CACNB2, NPPA |
| intracellular signal transduction (GO:0035556) | 2.39 | 6 | CACNA1C, AKAP9, RYR2, CASQ2, KCNH2, ANK2 |
| negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.68 | 6 | KCNE1, KCNE3, KCNQ1, KCNE2, KCNH2, CASQ2 |
| response to purine-containing compound (GO:0014074) | 4.67 | 6 | AKAP9, RYR2, CASQ2, HCN4, KCNQ1, KCNE1 |
| negative regulation of transmembrane transport (GO:0034763) | 5.38 | 6 | KCNE1, KCNE3, KCNQ1, KCNE2, KCNH2, CASQ2 |
| negative regulation of transporter activity (GO:0032410) | 5.59 | 5 | KCNQ1, KCNE1, CASQ2, KCNE3, KCNE2 |
| negative regulation of ion transmembrane transporter activity (GO:0032413) | 5.74 | 5 | KCNQ1, KCNE1, CASQ2, KCNE3, KCNE2 |
| ion homeostasis (GO:0050801) | 3.42 | 5 | CACNA1C, KCNJ2, RYR2, KCNH2, ANK2 |
| metal ion homeostasis (GO:0055065) | 3.61 | 5 | KCNJ2, CACNA1C, RYR2, KCNH2, ANK2 |
| regulation of response to stimulus (GO:0048583) | 1.54 | 5 | KCNQ1, JUP, CASQ2, NOS1AP, KCNE2 |
| membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 7.43 | 5 | KCNJ2, KCNQ1, KCNE1, KCNE2, KCNH2 |
| homeostatic process (GO:0042592) | 2.61 | 5 | KCNJ2, CACNA1C, RYR2, KCNH2, ANK2 |
| cell-cell signaling (GO:0007267) | 3.35 | 5 | AKAP9, CACNB2, CASQ2, RYR2, SCN1B |
| inorganic ion homeostasis (GO:0098771) | 3.43 | 5 | KCNJ2, CACNA1C, RYR2, KCNH2, ANK2 |
| cell communication involved in cardiac conduction (GO:0086065) | 6.73 | 5 | CACNA1C, SCN5A, RYR2, CASQ2, ANK2 |
| regulation of voltage-gated calcium channel activity (GO:1901385) | 6.59 | 5 | CACNB2, KCNE3, NOS1AP, KCNE2, NPPA |
| cellular macromolecule metabolic process (GO:0044260) | 0.93 | 5 | AKAP9, KCNE1, KCNH2, LIG3, NPPA |
| membrane repolarization (GO:0086009) | 7.02 | 5 | KCNJ2, KCNQ1, KCNE1, KCNE2, KCNH2 |
| positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 6.36 | 5 | RYR2, CACNB2, KCNE3, ANK2, KCNE2 |
| negative regulation of molecular function (GO:0044092) | 2.74 | 5 | KCNQ1, KCNE1, CASQ2, KCNE3, KCNE2 |
| regulation of ventricular cardiac muscle cell action potential (GO:0098911) | 7.33 | 5 | CACNA1C, RYR2, JUP, DSG2, NOS1AP |
| regulation of gene expression (GO:0010468) | 1.37 | 5 | JUP, KCNQ1, RYR2, ANK2, NOS1AP |
| macromolecule metabolic process (GO:0043170) | 0.83 | 5 | AKAP9, KCNH2, KCNE1, NPPA, LIG3 |
| negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.96 | 5 | KCNQ1, KCNE1, CASQ2, KCNE3, KCNE2 |
| positive regulation of blood circulation (GO:1903524) | 5.16 | 5 | KCNQ1, RYR2, SCN5A, NOS1AP, NPPA |
| positive regulation of calcium ion transmembrane transport (GO:1904427) | 5.69 | 5 | RYR2, KCNE3, ANK2, KCNE2, CACNB2 |
| cation homeostasis (GO:0055080) | 3.46 | 5 | KCNJ2, CACNA1C, RYR2, KCNH2, ANK2 |
| divalent metal ion transport (GO:0070838) | 4.15 | 5 | CACNA1C, KCNJ2, RYR2, CACNB2, ANK2 |
| membrane repolarization during action potential (GO:0086011) | 7.43 | 5 | KCNJ2, KCNH2, KCNE1, KCNE2, KCNQ1 |
| response to abiotic stimulus (GO:0009628) | 2.8 | 5 | KCNJ2, JUP, KCNJ8, RYR2, NPPA |
| divalent inorganic cation transport (GO:0072511) | 4.13 | 5 | CACNA1C, KCNJ2, CACNB2, RYR2, ANK2 |
| response to external stimulus (GO:0009605) | 2.55 | 5 | KCNJ2, RYR2, KCNJ8, JUP, NPPA |
| positive regulation of calcium ion transport (GO:0051928) | 5.06 | 5 | RYR2, CACNB2, KCNE3, ANK2, KCNE2 |
| chemical homeostasis (GO:0048878) | 2.97 | 5 | KCNJ2, CACNA1C, RYR2, KCNH2, ANK2 |
| cardiac muscle cell membrane repolarization (GO:0099622) | 7.43 | 5 | KCNJ2, KCNQ1, KCNE1, KCNE2, KCNH2 |
| positive regulation of heart contraction (GO:0045823) | 6.15 | 5 | KCNQ1, RYR2, SCN5A, NOS1AP, NPPA |
| negative regulation of cation channel activity (GO:2001258) | 6.26 | 5 | KCNQ1, KCNE1, CASQ2, KCNE3, KCNE2 |
| cellular homeostasis (GO:0019725) | 3.23 | 4 | KCNJ2, CACNA1C, RYR2, ANK2 |
| cellular component assembly (GO:0022607) | 2.14 | 4 | KCNJ2, JUP, CASQ2, ANK2 |
| positive regulation of metabolic process (GO:0009893) | 1.74 | 4 | AKAP9, NOS1AP, ANK2, KCNE2 |
| regulation of cardiac conduction (GO:1903779) | 5.57 | 4 | RYR2, CASQ2, NPPA, ANK2 |
| regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.68 | 4 | CACNA1C, RYR2, CASQ2, ANK2 |
| regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 4 | JUP, RYR2, LIG3, NOS1AP |
| regulation of sequestering of calcium ion (GO:0051282) | 5.07 | 4 | CACNA1C, RYR2, CASQ2, ANK2 |
| regulation of cellular component organization (GO:0051128) | 2.01 | 4 | LIG3, KCNE1, SCN1B, NPPA |
| second-messenger-mediated signaling (GO:0019932) | 4.65 | 4 | CACNA1C, RYR2, CASQ2, ANK2 |
| negative regulation of voltage-gated potassium channel activity (GO:1903817) | 7.53 | 4 | KCNQ1, KCNE1, KCNE3, KCNE2 |
| potassium ion import (GO:0010107) | 6.4 | 4 | KCNJ2, KCNJ8, KCNJ5, KCNE2 |
| cellular protein metabolic process (GO:0044267) | 1.63 | 4 | AKAP9, KCNH2, KCNE1, NPPA |
| single-organism metabolic process (GO:0044710) | 1.63 | 4 | AKAP9, KCNH2, KCNE1, NPPA |
| positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 4 | AKAP9, NOS1AP, ANK2, KCNE2 |
| regulation of signal transduction (GO:0009966) | 1.84 | 4 | JUP, CASQ2, NOS1AP, KCNE2 |
| regulation of protein metabolic process (GO:0051246) | 1.93 | 4 | AKAP9, SNTA1, NOS1AP, KCNE2 |
| response to mechanical stimulus (GO:0009612) | 4.41 | 4 | KCNJ2, JUP, RYR2, NPPA |
| sodium ion transmembrane transport (GO:0035725) | 5.23 | 4 | SCN5A, SCN4B, HCN4, SCN1B |
| animal organ development (GO:0048513) | 2.53 | 4 | CACNA1C, JUP, KCNJ8, KCNE2 |
| positive regulation of heart rate (GO:0010460) | 6.59 | 4 | KCNQ1, RYR2, SCN5A, NPPA |
| response to organophosphorus (GO:0046683) | 4.79 | 4 | AKAP9, KCNQ1, KCNE1, HCN4 |
| regulation of sodium ion transport (GO:0002028) | 5.4 | 4 | SCN5A, SNTA1, SCN4B, SCN1B |
| ventricular cardiac muscle cell membrane repolarization (GO:0099625) | 8.34 | 4 | KCNQ1, KCNH2, KCNE1, KCNE2 |
| regulation of sodium ion transmembrane transport (GO:1902305) | 5.86 | 4 | SCN5A, SNTA1, SCN4B, SCN1B |
| positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 6.96 | 4 | AKAP9, NOS1AP, NPPA, ANK2 |
| negative regulation of delayed rectifier potassium channel activity (GO:1902260) | 7.53 | 4 | KCNQ1, KCNE1, KCNE3, KCNE2 |
| calcium-mediated signaling (GO:0019722) | 5.24 | 4 | CACNA1C, RYR2, CASQ2, ANK2 |
| cellular metal ion homeostasis (GO:0006875) | 3.75 | 4 | CACNA1C, KCNJ2, RYR2, ANK2 |
| neurological system process (GO:0050877) | 2.64 | 4 | KCNQ1, CACNB2, KCNE1, SCN1B |
| regulation of biosynthetic process (GO:0009889) | 1.37 | 4 | JUP, RYR2, LIG3, NOS1AP |
| potassium ion export (GO:0071435) | 7.43 | 4 | KCNQ1, KCNH2, KCNE1, KCNE2 |
| cellular ion homeostasis (GO:0006873) | 3.57 | 4 | CACNA1C, KCNJ2, RYR2, ANK2 |
| calcium ion transport (GO:0006816) | 4.33 | 4 | CACNA1C, CACNB2, RYR2, ANK2 |
| establishment of protein localization (GO:0045184) | 2.53 | 4 | JUP, CACNB2, RYR2, ANK2 |
| response to stress (GO:0006950) | 1.8 | 4 | RYR2, KCNJ8, NPPA, LIG3 |
| response to cAMP (GO:0051591) | 5.08 | 4 | AKAP9, KCNQ1, KCNE1, HCN4 |
| regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 4 | JUP, RYR2, LIG3, NOS1AP |
| cellular cation homeostasis (GO:0030003) | 3.6 | 4 | CACNA1C, KCNJ2, RYR2, ANK2 |
| regulation of postsynaptic membrane potential (GO:0060078) | 5.72 | 4 | SCN5A, SCN4B, HCN4, SCN1B |
| cellular chemical homeostasis (GO:0055082) | 3.4 | 4 | KCNJ2, CACNA1C, RYR2, ANK2 |
| sodium ion transport (GO:0006814) | 4.75 | 4 | SCN5A, SCN4B, HCN4, SCN1B |
| regulation of calcium ion import (GO:0090279) | 5.08 | 4 | CACNA1C, RYR2, CASQ2, ANK2 |
| organelle organization (GO:0006996) | 2.02 | 4 | AKAP9, JUP, CASQ2, LIG3 |
| regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 4 | AKAP9, SNTA1, NOS1AP, KCNE2 |
| protein metabolic process (GO:0019538) | 1.45 | 4 | AKAP9, KCNH2, KCNE1, NPPA |
| regulation of release of sequestered calcium ion into cytosol (GO:0051279) | 5.44 | 4 | CACNA1C, RYR2, CASQ2, ANK2 |
| cellular response to cAMP (GO:0071320) | 5.82 | 4 | AKAP9, KCNQ1, KCNE1, HCN4 |
| membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915) | 8.34 | 4 | KCNQ1, KCNE1, KCNE2, KCNH2 |
| regulation of calcium ion transport into cytosol (GO:0010522) | 5.23 | 4 | CACNA1C, RYR2, CASQ2, ANK2 |
| regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881) | 6.9 | 4 | CACNA1C, RYR2, CASQ2, ANK2 |
| regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.59 | 4 | CACNA1C, RYR2, CASQ2, ANK2 |
| negative regulation of metabolic process (GO:0009892) | 1.93 | 3 | SNTA1, KCNQ1, LIG3 |
| cell-cell junction organization (GO:0045216) | 4.66 | 3 | JUP, ANK2, DSG2 |
| macromolecular complex subunit organization (GO:0043933) | 2.14 | 3 | KCNJ2, JUP, CASQ2 |
| calcium ion transmembrane transport (GO:0070588) | 4.67 | 3 | CACNA1C, CACNB2, RYR2 |
| calcium ion homeostasis (GO:0055074) | 3.97 | 3 | CACNA1C, RYR2, ANK2 |
| cell junction organization (GO:0034330) | 4.51 | 3 | JUP, ANK2, DSG2 |
| cellular response to drug (GO:0035690) | 5.48 | 3 | KCNH2, KCNQ1, KCNE2 |
| positive regulation of muscle contraction (GO:0045933) | 5.9 | 3 | NOS1AP, KCNQ1, NPPA |
| single-organism organelle organization (GO:1902589) | 2.68 | 3 | AKAP9, JUP, CASQ2 |
| cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 3 | KCNQ1, NPPA, LIG3 |
| circulatory system process (GO:0003013) | 4.38 | 3 | KCNJ8, NPPA, HCN4 |
| nitrogen compound metabolic process (GO:0006807) | 1.13 | 3 | KCNQ1, NPPA, LIG3 |
| positive regulation of striated muscle contraction (GO:0045989) | 6.96 | 3 | NOS1AP, KCNQ1, NPPA |
| anatomical structure morphogenesis (GO:0009653) | 2.53 | 3 | CACNA1C, RYR2, SCN5A |
| establishment of protein localization to plasma membrane (GO:0090002) | 5.2 | 3 | CACNB2, JUP, ANK2 |
| organic cyclic compound metabolic process (GO:1901360) | 1.26 | 3 | KCNQ1, NPPA, LIG3 |
| regulation of protein localization (GO:0032880) | 2.88 | 3 | CACNA1C, JUP, KCNE1 |
| nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 3 | KCNQ1, LIG3, NPPA |
| regulation of protein transport (GO:0051223) | 3.12 | 3 | CACNA1C, JUP, KCNE1 |
| negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 3 | SNTA1, KCNQ1, LIG3 |
| cellular divalent inorganic cation homeostasis (GO:0072503) | 3.96 | 3 | CACNA1C, RYR2, ANK2 |
| protein complex subunit organization (GO:0071822) | 2.6 | 3 | KCNJ2, JUP, CASQ2 |
| regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 3 | JUP, RYR2, LIG3 |
| positive regulation of protein metabolic process (GO:0051247) | 2.43 | 3 | AKAP9, NOS1AP, KCNE2 |
| macromolecular complex assembly (GO:0065003) | 2.55 | 3 | KCNJ2, JUP, CASQ2 |
| chemical synaptic transmission (GO:0007268) | 3.98 | 3 | AKAP9, CACNB2, SCN1B |
| positive regulation of cellular protein metabolic process (GO:0032270) | 2.49 | 3 | AKAP9, NOS1AP, KCNE2 |
| positive regulation of catalytic activity (GO:0043085) | 2.4 | 3 | AKAP9, RYR2, NOS1AP |
| regulation of protein modification process (GO:0031399) | 2.32 | 3 | AKAP9, SNTA1, NOS1AP |
| regulation of high voltage-gated calcium channel activity (GO:1901841) | 7.65 | 3 | CACNB2, NOS1AP, NPPA |
| positive regulation of voltage-gated calcium channel activity (GO:1901387) | 7.94 | 3 | CACNB2, KCNE3, KCNE2 |
| positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 3 | AKAP9, NOS1AP, KCNE2 |
| positive regulation of sodium ion transport (GO:0010765) | 6.23 | 3 | SCN5A, SCN4B, SCN1B |
| regulation of establishment of protein localization (GO:0070201) | 3.02 | 3 | CACNA1C, JUP, KCNE1 |
| regulation of catalytic activity (GO:0050790) | 1.97 | 3 | AKAP9, RYR2, NOS1AP |
| divalent inorganic cation homeostasis (GO:0072507) | 3.9 | 3 | CACNA1C, RYR2, ANK2 |
| regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 3 | JUP, RYR2, LIG3 |
| cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 3 | KCNQ1, NPPA, LIG3 |
| protein complex assembly (GO:0006461) | 2.78 | 3 | KCNJ2, JUP, CASQ2 |
| regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372) | 7.94 | 3 | KCNQ1, SCN5A, NPPA |
| sensory perception (GO:0007600) | 2.93 | 3 | KCNQ1, CACNB2, KCNE1 |
| cellular protein modification process (GO:0006464) | 1.79 | 3 | AKAP9, KCNH2, KCNE1 |
| response to calcium ion (GO:0051592) | 4.98 | 3 | SCN5A, RYR2, CASQ2 |
| macromolecule modification (GO:0043412) | 1.73 | 3 | AKAP9, KCNH2, KCNE1 |
| protein modification process (GO:0036211) | 1.79 | 3 | AKAP9, KCNH2, KCNE1 |
| cell adhesion (GO:0007155) | 2.82 | 3 | JUP, SCN1B, DSG2 |
| response to metal ion (GO:0010038) | 3.91 | 3 | SCN5A, RYR2, CASQ2 |
| establishment of localization in cell (GO:0051649) | 2.47 | 3 | CACNA1C, RYR2, ANK2 |
| regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514) | 8.12 | 3 | CACNB2, NOS1AP, NPPA |
| cytoskeleton organization (GO:0007010) | 3.22 | 3 | AKAP9, JUP, CASQ2 |
| response to inorganic substance (GO:0010035) | 3.56 | 3 | CASQ2, RYR2, SCN5A |
| SA node cell action potential (GO:0086015) | 7.94 | 3 | SCN5A, HCN4, ANK2 |
| heterocycle metabolic process (GO:0046483) | 1.31 | 3 | KCNQ1, LIG3, NPPA |
| cellular calcium ion homeostasis (GO:0006874) | 4.01 | 3 | CACNA1C, RYR2, ANK2 |
| anterograde trans-synaptic signaling (GO:0098916) | 3.98 | 3 | AKAP9, CACNB2, SCN1B |
| detection of stimulus (GO:0051606) | 3.22 | 3 | JUP, CASQ2, RYR2 |
| biological adhesion (GO:0022610) | 2.81 | 3 | JUP, SCN1B, DSG2 |
| establishment of protein localization to membrane (GO:0090150) | 4.14 | 3 | CACNB2, JUP, ANK2 |
| response to drug (GO:0042493) | 3.71 | 3 | KCNQ1, KCNH2, KCNE2 |
| regulation of membrane depolarization (GO:0003254) | 6.04 | 3 | SCN5A, HCN4, SCN1B |
| immune system process (GO:0002376) | 2.29 | 3 | CACNA1C, KCNJ8, LIG3 |
| phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 3 | AKAP9, KCNH2, NPPA |
| regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 3 | JUP, RYR2, LIG3 |
| positive regulation of cardiac muscle contraction (GO:0060452) | 7.24 | 3 | NOS1AP, KCNQ1, NPPA |
| phosphorus metabolic process (GO:0006793) | 2.15 | 3 | AKAP9, KCNH2, NPPA |
| system development (GO:0048731) | 2.92 | 3 | CACNA1C, KCNQ1, ANK2 |
| trans-synaptic signaling (GO:0099537) | 3.98 | 3 | AKAP9, CACNB2, SCN1B |
| synaptic signaling (GO:0099536) | 3.98 | 3 | AKAP9, CACNB2, SCN1B |
| membrane depolarization during AV node cell action potential (GO:0086045) | 8.34 | 3 | CACNA1C, CACNB2, SCN5A |
| regulation of intracellular protein transport (GO:0033157) | 3.8 | 2 | JUP, KCNE1 |
| heterotypic cell-cell adhesion (GO:0034113) | 6.43 | 2 | JUP, DSG2 |
| regulation of secretion (GO:0051046) | 3.2 | 2 | CACNA1C, KCNQ1 |
| regulation of intracellular transport (GO:0032386) | 3.58 | 2 | JUP, KCNE1 |
| positive regulation of response to stimulus (GO:0048584) | 2.18 | 2 | JUP, NOS1AP |
| positive regulation of homeostatic process (GO:0032846) | 4.38 | 2 | RYR2, CASQ2 |
| negative regulation of homeostatic process (GO:0032845) | 4.91 | 2 | RYR2, CASQ2 |
| cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042) | 7.94 | 2 | JUP, DSG2 |
| potassium ion homeostasis (GO:0055075) | 6.84 | 2 | KCNJ2, KCNH2 |
| cell surface receptor signaling pathway (GO:0007166) | 2.09 | 2 | RYR2, NPPA |
| enzyme linked receptor protein signaling pathway (GO:0007167) | 3.24 | 2 | RYR2, NPPA |
| vascular process in circulatory system (GO:0003018) | 4.65 | 2 | KCNJ8, NPPA |
| detection of chemical stimulus (GO:0009593) | 3.49 | 2 | RYR2, CASQ2 |
| organic cyclic compound biosynthetic process (GO:1901362) | 1.66 | 2 | LIG3, NPPA |
| signal transduction by protein phosphorylation (GO:0023014) | 3.79 | 2 | AKAP9, KCNH2 |
| positive regulation of signal transduction (GO:0009967) | 2.5 | 2 | JUP, NOS1AP |
| cell junction assembly (GO:0034329) | 4.86 | 2 | JUP, ANK2 |
| regulation of SA node cell action potential (GO:0098907) | 9.04 | 2 | RYR2, ANK2 |
| positive regulation of sequestering of calcium ion (GO:0051284) | 7.09 | 2 | RYR2, CASQ2 |
| regulation of cell proliferation (GO:0042127) | 2.41 | 2 | JUP, SCN5A |
| regulation of potassium ion export (GO:1902302) | 8.63 | 2 | KCNH2, NPPA |
| sensory perception of sound (GO:0007605) | 4.82 | 2 | KCNQ1, KCNE1 |
| positive regulation of voltage-gated potassium channel activity (GO:1903818) | 8.12 | 2 | NOS1AP, NPPA |
| regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 2 | JUP, RYR2 |
| desmosome organization (GO:0002934) | 7.53 | 2 | JUP, DSG2 |
| multi-organism process (GO:0051704) | 2.65 | 2 | KCNJ8, NPPA |
| positive regulation of signaling (GO:0023056) | 2.41 | 2 | JUP, NOS1AP |
| positive regulation of cytosolic calcium ion concentration (GO:0007204) | 4.56 | 2 | CACNA1C, RYR2 |
| regulation of atrial cardiac muscle cell action potential (GO:0098910) | 8.12 | 2 | RYR2, ANK2 |
| membrane depolarization during atrial cardiac muscle cell action potential (GO:0098912) | 9.04 | 2 | CACNA1C, CACNB2 |
| aromatic compound biosynthetic process (GO:0019438) | 1.7 | 2 | NPPA, LIG3 |
| heterocycle biosynthetic process (GO:0018130) | 1.7 | 2 | LIG3, NPPA |
| membrane depolarization during SA node cell action potential (GO:0086046) | 8.34 | 2 | SCN5A, ANK2 |
| cellular response to mechanical stimulus (GO:0071260) | 5.33 | 2 | KCNJ2, NPPA |
| membrane depolarization during Purkinje myocyte cell action potential (GO:0086047) | 9.04 | 2 | SCN5A, SCN1B |
| movement of cell or subcellular component (GO:0006928) | 2.61 | 2 | JUP, SCN1B |
| positive regulation of gene expression (GO:0010628) | 2.35 | 2 | NOS1AP, ANK2 |
| response to monoamine (GO:0071867) | 6.17 | 2 | RYR2, KCNQ1 |
| cellular response to monoamine stimulus (GO:0071868) | 6.29 | 2 | RYR2, KCNQ1 |
| response to catecholamine (GO:0071869) | 6.23 | 2 | RYR2, KCNQ1 |
| response to muscle stretch (GO:0035994) | 6.78 | 2 | RYR2, NPPA |
| organic substance biosynthetic process (GO:1901576) | 1.34 | 2 | NPPA, LIG3 |
| positive regulation of hydrolase activity (GO:0051345) | 2.91 | 2 | AKAP9, RYR2 |
| Purkinje myocyte to ventricular cardiac muscle cell signaling (GO:0086029) | 9.04 | 2 | RYR2, CASQ2 |
| regulation of anatomical structure size (GO:0090066) | 3.78 | 2 | KCNJ8, NPPA |
| regulation of sodium ion transmembrane transporter activity (GO:2000649) | 6.09 | 2 | SCN4B, SCN1B |
| cellular response to abiotic stimulus (GO:0071214) | 4.15 | 2 | KCNJ2, NPPA |
| calcium ion import (GO:0070509) | 5.57 | 2 | CACNB2, RYR2 |
| regulation of tube size (GO:0035150) | 4.79 | 2 | KCNJ8, NPPA |
| single organism cell adhesion (GO:0098602) | 3.63 | 2 | JUP, DSG2 |
| cell-cell adhesion (GO:0098609) | 3.34 | 2 | JUP, DSG2 |
| sensory perception of mechanical stimulus (GO:0050954) | 4.79 | 2 | KCNQ1, KCNE1 |
| response to caffeine (GO:0031000) | 6.84 | 2 | RYR2, CASQ2 |
| regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 7.65 | 2 | SCN5A, SCN1B |
| cellular response to epinephrine stimulus (GO:0071872) | 7.24 | 2 | RYR2, KCNQ1 |
| response to epinephrine (GO:0071871) | 6.96 | 2 | RYR2, KCNQ1 |
| cellular response to catecholamine stimulus (GO:0071870) | 6.33 | 2 | RYR2, KCNQ1 |
| nucleobase-containing compound biosynthetic process (GO:0034654) | 1.72 | 2 | LIG3, NPPA |
| maintenance of location (GO:0051235) | 4.77 | 2 | JUP, CASQ2 |
| regulation of intracellular signal transduction (GO:1902531) | 2.31 | 2 | NOS1AP, CASQ2 |
| regulation of hydrolase activity (GO:0051336) | 2.53 | 2 | AKAP9, RYR2 |
| potassium ion export across plasma membrane (GO:0097623) | 9.04 | 2 | KCNH2, KCNQ1 |
| regulation of heart rate by chemical signal (GO:0003062) | 8.12 | 2 | NOS1AP, KCNH2 |
| cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 2 | NPPA, LIG3 |
| sensory organ development (GO:0007423) | 4.82 | 2 | CACNA1C, KCNE2 |
| response to decreased oxygen levels (GO:0036293) | 4.09 | 2 | RYR2, NPPA |
| positive regulation of protein modification process (GO:0031401) | 2.7 | 2 | AKAP9, NOS1AP |
| regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 2 | JUP, RYR2 |
| muscle hypertrophy (GO:0014896) | 6.68 | 2 | RYR2, NPPA |
| striated muscle hypertrophy (GO:0014897) | 6.78 | 2 | RYR2, NPPA |
| phosphorylation (GO:0016310) | 2.63 | 2 | AKAP9, KCNH2 |
| negative regulation of cellular component organization (GO:0051129) | 3.35 | 2 | KCNE1, LIG3 |
| regulation of cellular protein localization (GO:1903827) | 3.43 | 2 | JUP, KCNE1 |
| cellular biosynthetic process (GO:0044249) | 1.37 | 2 | LIG3, NPPA |
| cell-cell junction assembly (GO:0007043) | 5.42 | 2 | JUP, ANK2 |
| regulation of protein targeting (GO:1903533) | 4.0 | 2 | JUP, KCNE1 |
| cell communication by electrical coupling (GO:0010644) | 7.02 | 2 | CACNA1C, RYR2 |
| positive regulation of cell communication (GO:0010647) | 2.41 | 2 | JUP, NOS1AP |
| response to hypoxia (GO:0001666) | 4.13 | 2 | RYR2, NPPA |
| regulation of blood vessel size (GO:0050880) | 4.8 | 2 | KCNJ8, NPPA |
| cardiac muscle hypertrophy (GO:0003300) | 6.84 | 2 | RYR2, NPPA |
| RNA metabolic process (GO:0016070) | 1.59 | 2 | LIG3, NPPA |
| cellular response to external stimulus (GO:0071496) | 4.2 | 2 | KCNJ2, NPPA |
| positive regulation of delayed rectifier potassium channel activity (GO:1902261) | 8.12 | 2 | NOS1AP, NPPA |
| regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 2 | JUP, RYR2 |
| cell-cell signaling involved in cardiac conduction (GO:0086019) | 8.12 | 2 | RYR2, CASQ2 |
| response to alkaloid (GO:0043279) | 4.83 | 2 | RYR2, CASQ2 |
| AV node cell action potential (GO:0086016) | 8.34 | 2 | SCN5A, SCN4B |
| atrial cardiac muscle cell action potential (GO:0086014) | 7.65 | 2 | KCNQ1, ANK2 |
| protein oligomerization (GO:0051259) | 3.71 | 2 | KCNJ2, JUP |
| regulation of peptidyl-cysteine S-nitrosylation (GO:2000169) | 8.12 | 2 | SNTA1, NOS1AP |
| response to hormone (GO:0009725) | 3.33 | 2 | NPPA, DSG2 |
| regulation of RNA metabolic process (GO:0051252) | 1.52 | 2 | JUP, RYR2 |
| detection of calcium ion (GO:0005513) | 7.24 | 2 | RYR2, CASQ2 |
| single organismal cell-cell adhesion (GO:0016337) | 3.69 | 2 | JUP, DSG2 |
| negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 2 | SNTA1, LIG3 |
| nucleic acid metabolic process (GO:0090304) | 1.46 | 2 | NPPA, LIG3 |
| Purkinje myocyte to ventricular cardiac muscle cell communication (GO:0086068) | 9.04 | 2 | RYR2, CASQ2 |
| cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 7.16 | 2 | CACNA1C, RYR2 |
| positive regulation of action potential (GO:0045760) | 7.33 | 2 | NOS1AP, SCN5A |
| response to lipid (GO:0033993) | 3.11 | 2 | KCNJ8, DSG2 |
| sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.33 | 2 | RYR2, ANK2 |
| cellular response to alkaloid (GO:0071312) | 6.2 | 2 | RYR2, CASQ2 |
| cellular response to caffeine (GO:0071313) | 7.65 | 2 | RYR2, CASQ2 |
| regulation of receptor activity (GO:0010469) | 4.98 | 2 | CASQ2, KCNE2 |
| embryonic morphogenesis (GO:0048598) | 3.72 | 2 | CACNA1C, RYR2 |
| protein phosphorylation (GO:0006468) | 2.89 | 2 | AKAP9, KCNH2 |
| cytosolic calcium ion transport (GO:0060401) | 5.74 | 2 | CACNA1C, RYR2 |
| calcium ion transport into cytosol (GO:0060402) | 5.78 | 2 | CACNA1C, RYR2 |
| homotypic cell-cell adhesion (GO:0034109) | 5.76 | 2 | JUP, DSG2 |
| reproductive process (GO:0022414) | 2.55 | 2 | NPPA, DSG2 |
| biosynthetic process (GO:0009058) | 1.32 | 2 | NPPA, LIG3 |
| macromolecule biosynthetic process (GO:0009059) | 1.61 | 2 | LIG3, NPPA |
| monovalent inorganic cation homeostasis (GO:0055067) | 4.93 | 2 | KCNJ2, KCNH2 |
| bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073) | 7.94 | 2 | JUP, DSG2 |
| response to oxygen levels (GO:0070482) | 4.02 | 2 | RYR2, NPPA |
| locomotion (GO:0040011) | 2.91 | 2 | JUP, SCN1B |
| heart development (GO:0007507) | 4.24 | 2 | CACNA1C, KCNJ8 |
| regulation of cytosolic calcium ion concentration (GO:0051480) | 4.41 | 2 | CACNA1C, RYR2 |
| cellular response to purine-containing compound (GO:0071415) | 7.53 | 2 | RYR2, CASQ2 |